15 min listen
Blazing New Trails in Rare Disease & CNS Clinical Studies: An Interview with Dr. Mark Opler
FromWCG Talks Trials
Blazing New Trails in Rare Disease & CNS Clinical Studies: An Interview with Dr. Mark Opler
FromWCG Talks Trials
ratings:
Length:
20 minutes
Released:
Jan 13, 2020
Format:
Podcast episode
Description
In this episode, Mark Opler, PhD, MPH, Chief Research Officer at WCG MedAvante-ProPhase sits down with Steve Smith, WCG’s President of Patient Advocacy to discuss the achievements in the field of CNS and rare disease clinical research. Dr. Opler and Steve highlight the unmet need of therapies available for rare disease, the importance of patient enrollment, ensuring efficacy and safety throughout a trial, and how time is of the essence in every study that is conducted.
Released:
Jan 13, 2020
Format:
Podcast episode
Titles in the series (67)
The Most Pressing Challenges in Psychiatry Clinical Trials with Leslie Citrome, MD, MPH by WCG Talks Trials